FDA NDC Directory · JSON-LD · Markdown
NDC 0591-2131 · HUMAN PRESCRIPTION DRUG · GEL
| Labeler / Manufacturer | Actavis Pharma, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA208011 |
| Dosage form / route | GEL · TOPICAL |
| Active ingredients | AZELAIC ACID (.15 g/g) |
| Marketing started | 20181119 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).